In the late 19th century, Friedrich Miescher isolated an unknown substance, something that was neither a protein nor lipid. Since it was found in a cell nucleus, Mischer named it a nuclein, later renamed deoxyribonucleic acid, or DNA for short [1]. However, it wasn’t until the mid-1900s that DNA—not protein—was proven through several experiments involving bacteriophages to be the macromolecule that carried genetic material. After that, two men by the name of Watson and Crick published a succinct paper detailing the double-helix structure of DNA, another milestone in the study of science and biology [2], and in 2003, the entirety of the human genome was sequenced and mapped.
It seems as though there are new discoveries every day in the field of science, especially in the studies of DNA and genetics. Since the discovery of DNA, there have been an increasing number of people and experiments invested in learning even more about the so-called “blueprint of life.” But even in the rapidly developing area of genome engineering and editing, there are discoveries that stand out. A particularly outstanding recent development is CRISPR-Cas9.
Today, there are thousands of known human genetic disorders, such as hemophilia, Huntington’s disease, Parkinson’s disease, and sickle cell disease, to name a few [3]. Now, to cure these genetic diseases, imagine using a new type of gene editing technology that could go into any human genome and cut out specific abnormal or disease-carrying segments of DNA, replacing them with different, more desirable strands of DNA [4]. Imagine using the same technology to purposefully engineer specific traits into or out of animal or human DNA; this is the ultimate goal of CRISPR-Cas9. Although the technology isn’t sophisticated enough to accomplish such specific engineering yet, CRISPR-Cas9 certainly opens up many intriguing opportunities in the world of genetic engineering.
The history of CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, begins a little further in the past than one might expect. In the decade leading up to the 21st century, scientists began identifying unusual repeating sequences of DNA in bacterial genomes. These short, repeating bacterial sequences of DNA were CRISPR. However, in the same way that the discovery of DNA proved to be underwhelming until DNA was proven to be genetic material, the discovery of CRISPR was of little importance until 2007, about thirty years after CRISPR were first identified. In a study led by Rodolphe Barrangou and Philippe Horvath, two researchers working at the company DuPont, scientists discovered that CRISPR were actually a type of defense mechanism used by bacteria against their assailants: viruses, phages, and plasmids [5]. The bacterial immune system breaks down the intrusive virus DNA, cutting the pathogenic DNA into unusable segments, which are then saved and inserted into the bacteria’s DNA, stored in the CRISPR spaces with an enzyme called Cas9 that has the ability to cut across DNA. The segments of virus DNA are then transcribed into RNA strands called guide RNA, or gRNA, which function as tags, duplicated from and designed to stick to viral DNA. Thus, if the bacteria is attacked by the same virus, gRNA identifies and tags the virus. Then Cas9 can cut up the intruder virus’s DNA, completely eliminating the virus. Essentially, bacteria can use old virus DNA they saved to identify new intruding viruses, and then Cas9 cuts up the intruding viral genome, protecting bacteria from harm [6, 7].
Scientists were quick to see how the CRISPR-Cas9 technique could be applied to human genetics. In 2013, researchers were able to use a version of the CRISPR-Cas9 system to cut DNA in both mouse cells and human cells using RNA guide sequences [8]. CRISPR-Cas9 cut the mouse and human DNA precisely where the scientists wanted it to, which showed the CRISPR-Cas9 system’s first real potential for becoming a precise gene-editing technique—not only for bacteria, but mammals and humans as well. Now, using any strand of selected DNA, CRISPR-Cas9 can potentially identify and edit desirable genes into or out of any human genome.
While the broader field of gene-editing is not a revolutionary idea, with the CRISPR-Cas9 technique, gRNA only tags dangerous viral DNA, only neutralizing dangerous viruses and making the CRISPR-Cas9 technique more effective and accurate than other genome editing techniques. The CRISPR-Cas9 technique’s precision, accuracy and affordability have made it one of the most popular techniques for gene-editing in 2016 [6, 9]. For example, a group of Chinese scientists have planned on using the CRISPR technique on a human patient, testing engineered cells in treating lung cancer [10]. Though the treatment is still recruiting participants, the experiments plans on inserting a programmed cell death gene into blood cells with CRISPR, then reintroducing those edited blood cells back into the patient. In cancer cells, cell death signals are ignored, resulting in the uncontrollable division of these cells. The introduced death gene is meant to prevent the metastasis and continued proliferation of these cancer cells. Numerous other experiments—from growing longer cashmere goat hair to engineering tougher crops to developing immune cells to attack cancer—involve CRISPR, which continues to be a diverse technique applicable to many fields [11, 12]. In the case of the cashmere goats, the researchers, using CRISPR, edited a specific follicle gene that resulted in longer and more cashmere [11]. For crops, CRISPR has been also used to successfully create strains of grain that are genetically engineered to be more disease-resistant and drought-resistant [12]. The success of these experiments show how many possibilities CRISPR can offer science and the world.
However, as with any new technology, there are arguments against the use and the effectiveness of CRISPR-Cas9. Ethical arguments against CRISPR and gene-editing include the fear that the ability to manipulate DNA may result in abnormal and unnatural animals or even humans. Selective control over undesirable or desirable traits may lead to eugenics [13, 14]. Ethics aside, many consider CRISPR-Cas9 too novel and too untested to be a viable option for gene-editing. Only in its early stages of development, CRISPR-Cas9 still requires refinement to answer criticism. How can CRISPR-Cas9 treat humans if no two human genomes are identical? Why would CRISPR be used when there are safer, more tested options on the market? What if removing a gene containing a disease makes the disease worse? Furthermore, the large size of the human genome, in comparison to bacterial DNA, often has identical sequences of DNA, which CRISPR-Cas9 could cut accidentally [14]. Nevertheless, since its early results with mammal DNA and plant DNA are promising, with more tests and more time, CRISPR-Cas9 may prove these critics wrong, and become the next breakthrough in science.
Although CRISPR-Cas9 currently remains in its developmental stage, with research focused solely on isolated human cells and animal subjects, it’s evident that the technology is quickly developing. Like the rest of the research dedicated to DNA and genetics, CRISPR-Cas9 has gained popularity with time. From 2011 to 2016 alone, there was a 1,453% increase in number of published scientific papers about CRISPR and for good reason: the potentials of CRISPR are limitless [15]. Whether it be creating more prosperous crops, curing cancer or altering human embryos, CRISPR-Cas9 has the potential to impact all aspects of human life and is a scientific development that deserves attention in the future.
Works Cited
- Dahm, Ralf. "Discovering DNA: Friedrich Miescher and the early years of nucleic acid research." Human Genetics Jan. 2008: 565-81. Print.
- "The Francis Crick Papers: The Discovery of the Double Helix, 1951-1953." U.S. National Library of Medicine. National Institutes of Health. Web. 18 Jan. 2017.
- "Specific Genetic Disorders." National Human Genome Research Institute (NHGRI). 18 Jan. 2017. Web. 19 Jan. 2017.
- "CRISPR/Cas9 GENE EDITING." CRISPR Therapeutics. Web. 17 Jan. 2017.
- Barrangou, Rodolphe, and Philippe Horvath. "The CRISPR System Protects Microbes against Phages, Plasmids." Microbe 2009: 224-30. Print.
- "Research Highlights: CRISPR." Broad Institute. Broad Institute, 2016. Web. 19 Jan. 2017.
- Pak, Ekaterina. "CRISPR: A game-changing genetic engineering technique." Science in the News. Harvard University: The Graduate School of Arts and Sciences, 31 July 2014. Web. 19 Jan. 2017.
- Cong, L., F. A. Ran, D. Cox, R. Barretto, N. Habib, P. D. Hsu, et. al. "Multiplex genome engineering using CRISPR/Cas systems." National Center for Biotechnology Information. U.S. National Library of Medicine, 15 Feb. 2013. Web. 19 Jan. 2017.
- "What is CRISPR-Cas9?" Your Genome. Wellcome Genome Campus, 19 Dec. 2016. Web. 19 Jan. 2017.
- "PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer." ClinicalTrials.gov. U.S. National Institutes of Health, Nov. 2016. Web. 19 Jan. 2017.
- Wang, Xiaolong, Bei Cai, Jiankui Zhou, et. al. "Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers." PLOS Journals. PLOS ONE, 22 Nov. 2016. Web. 19 Jan. 2017.
- Talbot, David. "10 Breakthrough Technologies 2016: Precise Gene Editing in Plants." MIT Technology Review. MIT Technology Review, 21 Feb. 2017. Web. 16 Apr. 2017.
- Andrew, Elise. "Genome Editing Poses Ethical Problems That We Cannot Ignore." IFLScience. IFLScience, 15 Aug. 2016. Web. 16 Apr. 2017.
- Rodriguez, E. "Ethical Issues in Genome Editing Using Crispr/Cas9 System." OMICS International. OMICS International, 24 Mar. 2016. Web. 16 Apr. 2017.
- "STAT’s stats of the year: 2016 by the numbers." STATnews.com. STAT, 28 Dec. 2016. Web. 19 Jan. 2017.